Newsletter | August 9, 2024

08.09.24 -- Scale And Sustainability In Single-Use Systems

SPONSOR

AI and machine learning are the buzzwords of the decade, often accompanied by lofty promises — but what do they really mean for biopharma? How can these technologies be adopted to improve biomanufacturing processes, testing, and quality? Join Bioprocess Online Live for an exploration into the practical applications of AI/ML in biomanufacturing, its barriers to adoption, and how regulators can help standardize use across the industry. Registration is free thanks to the support of Atum Bio.

FOCUS ON FACILITIES DESIGN

Scale And Sustainability In Single-Use Systems

I had the opportunity to cover a lot of ground on considerations for single-use technologies in biopharmaceutical manufacturing with Mark Petrich, Ph.D. when he joined me as a guest expert on the Bioprocess Online Live event Single Use Technologies For Bioprocessing: An Essential Update. Here are some of his insights on single-use scale and lifecycle management.

Steps For Proper Cleaning Validation

Examine the steps of cleaning validation for both low-volume and high-volume manufacturers and the important role these studies play.

Enhancing Facility Operations with Digital Twin Technology

Join us for an insightful webinar where we explore the transformative power of Digital Twin technology in modern facility management

Product D-Value Studies: A Critical Tool In Sterilization Process Development

Learn what questions to ask when developing a sterilization method and the critical tool that can help guide your decisions.

Embarking On A Successful Cleanroom Project: Conception To Delivery

Learn how you can obtain comprehensive solutions for cleanroom projects that help you ensure regulatory compliance and operational efficiency.

FACILITIES DESIGN SOLUTIONS

Cleanroom Facility Planning: The Right Direction, From The Start - AES Clean Technology, Inc.

Overview Of Biological Indicator And Sterilization Monitoring Systems - Mesa Laboratories

NEW PODCAST EPISODE

The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.

Kristin Yarema, Ph.D. says CAR T-cell therapies have to become a one-to-many proposition, if their early autologous success can live up to the promise of offering widespread accessibility to life-saving treatments. On the Business of Biotech, we learn how the newly appointed CEO of Poseida Therapeutics is positioning the company to crack the allogeneic CAR T code and how strategic collaborations with the likes of Astellas and Roche are fueling the effort.

FOCUS ON PROCESS ENGINEERING

How Eli Lilly's Making Peptides Faster And More Reliably

Three company leaders answer questions about the IE2b project, which is receiving an ISPE 2024 Facility of the Year Award for its ingenuity of complexity.

A Focus On Cell Therapy: CAR-T, CAR-NK, And Beyond

As the landscape of CAR T-cell therapies evolves, these treatments are becoming more precise in targeting cancer cells and overcoming production challenges, and are poised to revolutionize oncology.

A Lean, Agile Business Model To Deliver High-Quality Oncologic Treatments

No two journeys through the drug pipeline are the same; the ability to leverage a variety of approaches for different products is what sets one lean biotech company apart.

The High Cost Of Going Cheap

Developers often aim to cut expenses during development. Discover the long-term outcomes of cost-effective measures like using RUO leukopaks compared to investing in high-quality GMP-grade vectors.

Accelerate Your R&D And QC With These 3 Key Analysis Methods

Learn about three key thermal analysis methods for fast and effective characterization and quality control: differential scanning calorimetry, thermogravimetric analysis, and sorption analysis.

Process Validation: A Critical Step In A Biopharma Product's Lifecycle

Process validation is a critical step in the successful commercialization of a new biopharmaceutical. Learn about the challenges and the importance of applying it throughout the entire product lifecycle.

Outsourcing Process Development: Key Considerations For Biopharma

In Best Practices for Outsourcing Process Development, a panel of experts discussed four themes that may help drive the best outcomes when vetting process development service providers.

AAV Titer Estimation With Mass Photometry

How do new mass photometers, featuring a new titer estimation tool, perform as a powerful analysis technique when used to evaluate the quality of AAV samples.

Streamline Microbial Process Development To Reach Toxicology Trials Faster

For biopharmas looking to outsource their early phase development, consider working with a CDMO partner that has the knowledge and experience to navigate microbial fermentation and complex process development.

High Yield Protein Production System For Suspension CHO Cells

Reduced the risk of contamination caused by repeated handling of the culture during transient protein production in suspension CHO cells.

Understanding Process Development Of Antibody-Drug Conjugates In Preclinical And Early Phase Clinical Trials

Examine a platform process that is emerging as a simplified and reliable solution for ADC manufacturing, offering efficient process development, purification techniques, and optimization strategies.

The Key Steps In Analytical Method Development, Qualification, And Validation

Review how following regulatory guidelines and partnering with a reliable contract biologic manufacturer ensures the highest standards are met in pharmaceutical research and quality control.

Technical Transfers: Ensuring Successful Scaling Of Client Processes

Optimize your technical transfer process using built-for-purpose, cloud-connected systems and obtain results that translate effectively to other facilities.

Embracing Quality-By-Design For Enhanced Development Strategies

In the biopharmaceutical development world, Quality by Design cuts risk, streamlines processes, and speeds up regulatory approval.

Bringing Higher Resolution, Faster Analysis To Human Microbiome Profiling

Dr. Anne-Grethe Reichelt, International Sales and BD Manager at Bio-Me, discusses the current landscape of microbiome research, gaps in microbiome analysis, and the exciting possibilities ahead.

Antibody-Drug Conjugates: Next-Generation Linker Technology For IND Submissions

Review case studies and explore the complexities of oligonucleotide design, GMP standards for ADCs, and how developability can play a significant role in selecting ADC leads with high potential.

A Hybrid Approach For Optimizing Transient Protein Expression In CHO Cells

When choosing between protein expression formats such as transient versus stable pools, considerations include speed, cost, titre, and product quality.

Speeding-Up Analysis And Fast-Tracking mRNA Development

mRNA therapeutics have the potential to address a variety of diseases, and understanding mRNA molecules and access faster analytical solutions are crucial elements for the rapid development of these therapies.

Delivery Success In Gene Editing: Focusing On Lipid Nanoparticles To Show Effectiveness

Delve into the importance of delivery success in gene editing and review the use of viral vectors and lipid nanoparticles as two approaches to improve this aspect.

PROCESS ENGINEERING SOLUTIONS

Developability Assessment - JOINN Biologics

Pentamice Fact Sheet - Curia

The Only Plug-And Play, Ready In Minutes, In-Line Multiparameter PAT Platform - 908 Devices

Benchtop Macro Mass Photometer: KaritroMP - Refeyn

Connect With Bioprocess Online: